Models & Molecules
by enpicom
Melody Shahsavarian | Agentic AI and the Digital Transformation of…
About this podcast
At the intersection of computation and biology, Models & Molecules explores how data, algorithms, and science come together to design the medicines of tomorrow.
Each episode features candid conversations with the people shaping this transformation, from pharma R&D leaders to computational biologists and AI innovators.
Produced by ENPICOM, Models & Molecules offers a rare look behind the buzzwords of AI-driven discovery, uncovering the practical realities, lessons learned, and moments of insight that emerge when biology meets computation.
Episodes
- Melody Shahsavarian | Agentic AI and the Digital Transformation of Pharma R&D · 1 h 0 minIn this special in-person episode, recorded in San Diego, we sit down with Melody Shahsavarian, Senior Director of Data Strategy and Digital Transformation at Eli Lilly. Before…
- Iddo Weiner | Data, moats, and open science: Building scalable AI applications for bio · 49 minIn this episode, we sit down with Iddo Weiner, co-founder and CSO of Converge Bio, to discuss the evolving biotech and AI landscape: where models, data, and scale actually create…
- Talip Uçar | Inside Boltz's open-source bet on the future of AI-driven drug discovery · 45 minWhen an AI model generates an image, you can tell at a glance whether it's any good. In life sciences, that feedback loop is fragmented across data, modelling, experiments, and…
- Steve Comeau | From novel binder design to the realities of AI in complex therapeutics · 46 minGenerative models can now propose novel antibody sequences from antigen structure alone, but how far does that actually get you? In this episode, we sit down with Principal…
- Jiwon Kim | From lab-in-the-loop to zero-shot: The role of cloud and AI agents · 46 minJiwon Kim, Product Lead at AWS AI Life Sciences, joins Models & Molecules to break down pharma’s digital shift: where cloud and software are becoming core infrastructure for…
- Do Soon Kim | Navigating the convergence of tech and pharma · 46 minIn this episode of Models & Molecules, Do Soon Kim, Head of Product at Xaira Therapeutics, discusses his journey in the biotech and AI sectors, emphasizing the importance of…
- Jaap Goudsmit | From rabies to COVID: Antibody discovery in the age of AI · 55 minIn this episode of Models & Molecules, Jaap Goudsmit, MD, PhD, immunologist, epidemiologist, and one of the scientific forces behind Crucell, the Dutch biotech acquired by…
- René Hoet | Taking risks and driving innovation in biopharma · 43 minIn this episode of Models & Molecules, René Hoet reflects on game-changing technologies like phenotypic screening, the unique innovation dynamics of small biotechs versus large…







